Psyched Wellness (PSYC.C) released data from the National Research Council of Canada (NRC) on studies on the neuroprotective properties of their Amanita muscaria mushroom extract, AME-1. The study kicks…
PSYC.C
Psyched Wellness (PSYC.C) released the results and data from the three month oral toxicity preclinical trial on its amanita muscaria mushroom (AME-1) extract today, and enjoyed a substantial 19%…
Death & children’s novels When I think about Amanita Muscaria the first two things that come to mind are death, and children’s novels. Amanita Muscaria is arguably the…
Psyched Wellness (PSYC.C) announced that they have completed extraction of AME-1 and have shipped it to their contract research organization in (CRO) partner labs in Asia. The AME-1 was…
PsyBio Therapeutics (PSYB.V) announced they have filed a new provisional patent application with the US Patent and Trademark Office. The patent, titled Optimized Methods for the Production of Psilocybin…
Psyched Wellness (PSYC.C), a life sciences company focused on the production and distribution of functional and psychedelic mushrooms, announced today that it has contracted the Nation Research Council of…
Psyched Wellness (PSYC.C) announced they are initiating their next pre-clinical study on their Amanita Muscaria extract (AME-1) with their Clinical Research Organisation partner KGK Science. This newest study is…